Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Smith & Nephew Plc SN. Capital Markets Event



  Smith & Nephew Plc (SN.) - Capital Markets Event

RNS Number : 2375S
Smith & Nephew Plc
28 November 2012
 



 

Smith & Nephew Capital Markets Event

 

28 November 2012

 

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology
business, is holding a Capital Markets Event for institutional investors and
financial analysts commencing today in York, UK through to Friday 30 November.

 

There will be presentations from the business leaders focusing on Smith &
Nephew's strategic priorities and how we are delivering against these. The
event will be hosted by Olivier Bohuon, Chief Executive Officer, and Adrian
Hennah, Chief Financial Officer.

 

Presentations will be audio webcast live on Thursday, 29 November from 8.45am
GMT (3.45am Eastern Time) on Smith & Nephew's corporate website
(www.smith-nephew.com/investor-centre) and archived after the event.

 

No new material information will be disclosed, nor will there be any
additional statement on current trading further to Smith & Nephew's Q3 Results
statement on 1 November 2012.

 

                                  -  ends  -

 

Enquiries

 

Investors/Analysts

Kim Gunthorp

Smith & Nephew
                                                                 +44 (0)20
7401 7646

 

Media

Charles Reynolds

Smith &
Nephew                                                                  +44
(0)20 7401 7646

 

About Smith & Nephew

 

Smith & Nephew is a global medical technology business dedicated to helping
improve people's lives.  With leadership positions in Orthopaedic
Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith &
Nephew has almost 11,000 employees and a presence in more than 90 countries.
Annual sales in 2011 were nearly $4.3 billion.  Smith & Nephew is a member of
the FTSE100 (LSE: SN, NYSE: SNN).

 

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth and
trading margins, market trends and our product pipeline are forward-looking
statements. Phrases such as "aim", "plan", "intend", "anticipate",
"well-placed", "believe", "estimate", "expect", "target", "consider" and
similar expressions are generally intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual results to
differ materially from what is expressed or implied by the statements. For
Smith & Nephew, these factors include: economic and financial conditions in
the markets we serve, especially those affecting health care providers, payors
and customers; price levels for established and innovative medical devices;
developments in medical technology; regulatory approvals, reimbursement
decisions or other government actions; product defects or recalls; litigation
relating to patent or other claims; legal compliance risks and related
investigative, remedial or enforcement actions; strategic actions, including
acquisitions and dispositions, our success in integrating acquired businesses,
and disruption that may result from changes we make in our business plans or
organisation to adapt to market developments; and numerous other matters that
affect us or our markets, including those of a political, economic, business
or competitive nature. Please refer to the documents that Smith & Nephew has
filed with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith & Nephew's most
recent annual report on Form 20-F, for a discussion of certain of these
factors.

 

Any forward-looking statement is based on information available to Smith &
Nephew as of the date of the statement. All written or oral forward-looking
statements attributable to Smith & Nephew are qualified by this caution. Smith
& Nephew does not undertake any obligation to update or revise any
forward-looking statement to reflect any change in circumstances or in Smith &
Nephew's expectations.

 

^à^ Trademark of Smith & Nephew.  Registered US Patent and Trademark Office.

 

                     This information is provided by RNS
           The company news service from the London Stock Exchange
 
END
 
 
MSCEALFPAASAFFF -0- Nov/28/2012 14:28 GMT
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement